Sleep Apnea and Cardiovascular Disease

ObjectiveTo evaluate blood pressure and humoral vasoconstrictor responses to recurrent episodes of obstructive sleep apnea and the effects of therapy by means of continuous positive airway pressure.Patients and methodsWe prospectively evaluated overnight changes in hemodynamics, oxygen saturation, t

Effects of obstructive sleep apnea on endothelin-1 and blood pressure.

Plasma Aldosterone Is Related to Severity of Obstructive Sleep Apnea in Subjects With Resistant Hypertension

Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea.

Aldosterone Excretion Among Subjects With Resistant Hypertension and Symptoms of Sleep Apnea

To assess the effect of obstructive sleep apnea treatment on plasma renin activity (PRA) and plasma aldosterone seven male patients were studied under two conditions: untreated and treated with nasal continuous positive airways pressure (CPAP). PRA and plasma aldosterone were measured at 10-min intervals for both nights. CPAP treatment diminished the urinary and Na+ excretion, whereas plasma volume increased. The mean levels of PRA and aldosterone were significantly enhanced by the treatment, increasing respectively from 1.5 +/- 0.3 to 3.0 +/- 0.7 ngAI ml-1.hr-1 (p less than 0.05) and from 8.0 +/- 1.0 to 12.0 +/- 1.7 ng.100 ml-1 (p less than 0.05). PRA curves reflected the overall sleep structure as similarly described in normal subjects. The apnea-induced sleep disturbance led to flat PRA profiles and the restoration of a normal sleep pattern by treatment restored the PRA oscillations related to the sleep cycles and consequently restored aldosterone oscillations. The mean amplitude of these oscillations increased respectively from 1.0 +/- 0.1 to 1.8 +/- 0.4 ngAI ml-1.hr-1 and from 5.4 +/- 1.2 to 10.9 +/- 1.9 ng.100 ml-1. These results suggest that CPAP treatment modifies the nocturnal patterns of PRA and aldosterone by increasing their mean levels and their oscillation amplitude. This indicates increased secretion, which contributes to the normalization of urine and Na output.

/pdf/obstructive-sleep-apnea-treatment-peripheral-and-central-gch2morg7q.pdf

Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone.

We previously described a strong concordance between nocturnal oscillations in plasma renin activity and sleep cycles. To examine whether modifying renal renin content or release influences the response to central stimuli linked to sleep stage alternation, plasma renin activity was measured every 10 minutes from 11:00 PM to 8:00 AM in three groups of six subjects. The first group received one 40 mg dose of the diuretic furosemide; the second group underwent the night experiment after 3 days on a low sodium diet; the third group received one 100 mg dose of the beta-blocker atenolol. Each subject underwent a control night when a placebo was given. The nocturnal curves were analyzed with a pulse detection program. For the control nights, 74 of the 83 sleep cycles were associated with significant plasma renin activity oscillations; non-rapid eye movement sleep occurred in the ascending portions and rapid eye movement sleep in the declining portions of the oscillations. These oscillations persisted in the three groups of subjects during the experimental nights and the relation with the sleep stages was not disturbed. Acute stimulation by furosemide amplified the oscillations and led to a general upward trend of the nocturnal profiles. Similarly, a low sodium diet, which led to a slow increase in renal renin content, provoked large oscillations with high initial levels. However, in both cases the mean relative amplitude of the oscillations, expressed as a percentage of the nocturnal means, was similar to that of the control nights and approximated 60%.(ABSTRACT TRUNCATED AT 250 WORDS)

Modulation of episodic renin release during sleep in humans.

This study examined the relationship between aldosterone secretion and sleep stages in conjunction with two aldosterone regulating hormone systems, the renin-angiotensin system (RAS) and adrenocorticotropin (ACTH), and also K+. Nocturnal plasma patterns of aldosterone, plasma renin activity (PRA), ACTH and K+ were established in blood collected at 10-min intervals in two groups of 6 subjects. Both groups underwent two 9 hour overnight-studies, consisting of one control night and one experimental night. The first group was maintained on a low Na diet and the other was given a beta-blocker, atenolol. Polygraphic recordings of sleep were scored according to established criteria. For the control night, REM sleep usually began at peak level or in the descending phase of aldosterone oscillations. As previously described, PRA reflected REM-NREM sleep alteration, levels increased in NREM and decreased during REM sleep. ACTH fluctuations did not oscillate with sleep stages, but levels were very seldom in the ascending phase at REM sleep onset. Plasma K+ remained almost constant throughout the night. The relative importance of the ACTH and the RAS on nocturnal aldosterone secretion and the relationship between aldosterone oscillations and sleep stages remained unclear. Modulating renin levels by either consuming a low Na diet or administration of a beta-blocker enabled this relationship to be clarified. The RAS dominated aldosterone secretion when stimulated by a low sodium diet. Aldosterone oscillations then reflected PRA oscillations with a delay of about 20 min and the relationship of aldosterone to sleep stages was dependent on the relationship of PRA with sleep stages. Atenolol depressed PRA and in this case aldosterone levels reflected those of ACTH with a delay of about 10 min. To conclude, this study shows that the nocturnal secretion of aldosterone is under control of both the RAS and ACTH. Stimulating and depressing the RAS revealed that the relationship of aldosterone to sleep stages is dependent on the relationship of these hormonal systems to sleep stages.

Nocturnal oscillations of plasma aldosterone in relation to sleep stages

Overnight studies conducted in 10 male volunteers showed that the effect of awakening on aldosterone and its main regulatory hormonal systems depends on the time of its occurrence. Waking periods in the latter half of the night induced concomitant increases in plasma levels of aldosterone and ACTH, whereas plasma renin activity tended to decrease. No effect was apparent, when subjects were awoken during the first hours of sleep, which is known to be a quiescent period of adrenocorticotropic activity. These results provide evidence of the dominant influence of ACTH during the second half of the night insuring the regulation of aldosterone during waking periods.

M. O. Krauth

Papers

Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone.

Modulation of episodic renin release during sleep in humans.

Nocturnal oscillations of plasma aldosterone in relation to sleep stages

Effect of awakening on aldosterone.